RISK FACTOR PREDICTIVE OF TRANSPLANT FREE SURVIVAL IN A LARGE COHORT OF PSC PATIENTS IN THE UK

RISK FACTOR PREDICTIVE OF TRANSPLANT FREE SURVIVAL IN A LARGE COHORT OF PSC PATIENTS IN THE UK

Bibliographic Details
Main Authors:	Srivastava, B, Spiess, K, Brown, M, Muriithi, A, Dawwas, M, Alexander, G, Sandford, R, Rushbrook, S, Chapman, R, Consortium, UK-PSC
Format:	Conference item
Published:	2013

Similar Items

PHENOTYPIC DESCRIPTION OF A LARGE COHORT OF PSC PATIENTS IN THE UK
by: Srivastava, B, et al.
Published: (2011)

FINE MAPPING OF THE IL-2/IL-21 AND IL2RA LOCI IN PRIMARY SCLEROSING CHOLANGITIS
by: Srivastava, B, et al.
Published: (2012)

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
by: Srivastava, B, et al.
Published: (2012)

FINE MAPPING OF THE IL-2/IL-21 AND IL2RA LOCI IN PRIMARY SCLEROSING CHOLANGITIS
by: Srivastava, B, et al.
Published: (2012)

A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
by: de Vries, E, et al.
Published: (2017)

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
by: Goode, EC, et al.
Published: (2018)

The colon and PSC: new liver, new danger?
by: Chapman, R
Published: (1998)

Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
by: Faouzi Djebbari, et al.
Published: (2020-01-01)

In vivo survival and differentiation of Friedreich ataxia iPSC‐derived sensory neurons transplanted in the adult dorsal root ganglia
by: Serena Viventi, et al.
Published: (2021-08-01)

PSC, AIH and overlap syndrome in inflammatory bowel disease.
by: Trivedi, P, et al.
Published: (2012)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
by: Chapman, R
Published: (2010)

Personal Genome Project UK (PGP-UK): a research and citizen science hybrid project in support of personalized medicine
by: Pgp-Uk Consortium,, et al.
Published: (2018)

TISSUE DISTRIBUTION OF AN AUTOANTIGEN SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Lo, S, et al.
Published: (1992)

ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Bloom, S, et al.
Published: (1992)

Studies on immune regulation for allogeneic iPSC-based transplantation
by: Ken-ichiro Seino
Published: (2022-12-01)

Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
by: Sebastian V Rojas, et al.
Published: (2017-01-01)

UK cancer survival statistics
by: Beral, V, et al.
Published: (2010)

UK cancer survival statistics.
by: Beral, V, et al.
Published: (2010)

Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice
by: Karim Azzag, et al.
Published: (2022-09-01)

The UK kidney donor risk index poorly predicts long-term transplant survival in paediatric kidney transplant recipients
by: Jon Jin Kim, et al.
Published: (2023-06-01)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
by: Shanahan, J, et al.
Published: (1998)

iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants
by: Mohammad Afzal Khan, et al.
Published: (2019-09-01)

The UK10K project identifies rare variants in health and disease
by: UK10K Consortium, et al.
Published: (2017)

Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy
by: Gun-Sik Cho, et al.
Published: (2017-01-01)

Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual
by: Kannan V. Manian, et al.
Published: (2018-05-01)

Long-Term Transplant Effects of iPSC-RPE Monolayer in Immunodeficient RCS Rats
by: Deepthi S. Rajendran Nair, et al.
Published: (2021-10-01)

Liver specification of human iPSC-derived endothelial cells transplanted into mouse liver
by: Kiryu K. Yap, et al.
Published: (2024-05-01)

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Mehal, W, et al.
Published: (1993)

Association of Digoxin Use With Transplant‐Free Interstage Survival in Infants Palliated With a Stage 1 Hybrid Procedure
by: Reshma K. Reddy, et al.
Published: (2023-10-01)

Transplant and recipient factors in prediction of kidney transplant outcomes: a UK-wide paired analysis
by: Dumbill, R, et al.
Published: (2022)

Large-scale innovation and change in UK higher education
by: Stephen Brown
Published: (2013-09-01)

Enhanced cytokine mRNA expression in Primary Sclerosing Cholangitis (PSC) and autoimmune liver diseases.
by: Mitchell, S, et al.
Published: (1997)

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.
by: Williamson, K, et al.
Published: (2015)

Developing Humanized Animal Models with Transplantable Human iPSC-Derived Cells
by: Min Ma, et al.
Published: (2024-01-01)

Therapeutic Potential of Patient iPSC-Derived iMelanocytes in Autologous Transplantation
by: Li-Ping Liu, et al.
Published: (2019-04-01)

Impact of antigen identification on transplant free survival in interstitial lung disease
by: Margaret Kypreos, et al.
Published: (2023-10-01)

Large-scale engineering of hiPSC-derived nephron sheets and cryopreservation of their progenitors
by: Loes E. Wiersma, et al.
Published: (2022-05-01)

INAPPROPRIATE EXPRESSION OF BLOOD-GROUP ANTIGENS ON THE BILIARY EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Bloom, S, et al.
Published: (1990)

UK cancer survival statistics Authors' reply
by: Beral, V, et al.
Published: (2011)

Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database
by: Daniela Goyes, et al.
Published: (2021-07-01)